Antileishmanial activity of the ether phospholipid ilmofosine
- 1 March 1993
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 87 (2) , 217-219
- https://doi.org/10.1016/0035-9203(93)90499-g
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Short- and Long-Term Tolerability Study of the Thioether Phospholipid Derivative Ilmofosine in Cancer Patients1Published by S. Karger AG ,1989
- Recent developments in the chemotherapy of leishmaniasisTrends in Pharmacological Sciences, 1988
- Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future StrategiesClinical Infectious Diseases, 1988
- Ilmofosine (BM 41.440), a new cytotoxic etherphospholipidDrugs of the Future, 1988
- Metabolism of ether lysophospholipids in Leishmania donovani promastigotesMolecular and Biochemical Parasitology, 1987
- Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patientsLipids, 1987
- Clinical phase I pilot study of the alkyl lysophospholipid derivative ET‐18‐OCH3Lipids, 1987
- The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovaniBiochemical Pharmacology, 1987
- Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotesMolecular and Biochemical Parasitology, 1987
- Synthesis of Phospholipids inLeishmania donovaniHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1980